Image

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

Recruiting
60 years and older
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to determine if the Fractionated Laser Resurfacing (FLR) procedure can protect one forearm/wrist from precancerous actinic keratosis (AKs) as well as prevent skin cancer in older subjects with active AKs. This study builds on a similar study ongoing at the Dayton Veterans Administration dermatology clinic. This study is also testing if a photograph of the skin can be used to predict where the AKs and an skin cancers will form.

Eligibility

Inclusion Criteria:

  • Adult Males and Females aged 60 and older
  • Have at least 5 AKs on each forearm/wrist, but no more than 10 to allow for easy monitoring
  • Skin type fair (Fitzpatrick I-II)
  • Females must be post-menopausal and not be on systemic hormone replacement therapy
  • Able to comprehend procedures and risks

Exclusion Criteria:

  • More than 10 AKs on an extremity
  • AKs that are large (2-3+, hyperkeratotic grade 3 lesions)
  • AKs that are very thick (>3 mm)
  • Medical history of diabetes
  • History of poor wound healing or scarring
  • Large tattoos that can interfere with study
  • Other serious health issues and other skin diseases that could interfere with the study
  • Recent (within 1 year) field therapies such as efudex cream or PDT to forearms/wrists.
  • Planning to leave region in next 5 years
  • Subjects with allergies to xylocaine will be excluded if they need this topical anesthetic.

Study details
    Actinic Keratoses
    Aging
    Non-Melanoma Skin Cancer

NCT06428721

Wright State University

27 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.